Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/REGN
icon
Up to 4x
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Regeneron Pharmaceuticals Inc (REGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Regeneron Pharmaceuticals (REGN) trades at $781.49, down 1.48% on the day, with a bullish technical signal supported by moving averages. The company shows strong fundamentals with a P/E of 19.34, net income margin of 27.86%, and consistent earnings beats in recent quarters. However, it faces headwinds from a class action lawsuit related to clinical trial disclosures, with multiple law firms alerting investors ahead of a September 14, 2026 deadline.
The outlook remains positive due to robust profitability and growth catalysts like EYLEA HD and DUPIXENT, but legal risks and trial uncertainties pose significant near-term volatility. Analyst consensus is strongly bullish with a $760.45 price target, though investors should weigh litigation impacts against fundamental strength.
Read full analysis

Key Stats

  • Market Cap
    $80.46B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $555.51
  • Typical Hold Time
    -
  • Enterprise Value
    $75.17B
  • Div Yield
    0.48%
  • Trading Activity
    -
$781.49
52W Low: $555.51
25 Sep 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $555.51 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Most Recent News

Content is generated by Aura AI

Oklo CEO sells 120,000 shares, raising $4.6 million in a major stock sale.

Jacob Dewitte, CEO of Oklo, sold 120,000 shares of the company, generating $4.6 million from the transaction. This significant sale may indicate a strategic move by the CEO or a personal financial decision. Investors will watch closely for any impact...

Market News
1 hour ago
Reuben Gregg Brewer
Neutral
Oklo CEO sells 120,000 shares, raising $4.6 million in a major stock sale.

Larry Ellison cancels $7.5B Oracle stock sale, signaling strong confidence in AI cloud growth.

Larry Ellison, Oracle's controlling shareholder, canceled a planned $7.5 billion stock sale, signaling his confidence in the company's future amid strong AI cloud growth. The cancellation removes selling pressure as Oracle's stock had fallen about 16...

Market News
4 hours ago
24/7 Wall Street
Bullish
news icon
Larry Ellison cancels $7.5B Oracle stock sale, signaling strong confidence in AI cloud growth.

Medtronic offers higher dividend yield and growth, Abbott excels in dividend history and diversification.

Medtronic and Abbott are both strong dividend-paying medical device companies, but Medtronic currently offers a higher dividend yield of 3.11% and stronger near-term growth prospects, including accelerating revenue and a planned diabetes business sep...

Analyst Insights
4 hours ago
24/7 Wall Street
Bullish
news icon
Medtronic offers higher dividend yield and growth, Abbott excels in dividend history and diversification.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $80.46B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $555.51
  • Typical Hold Time
    -
  • Enterprise Value
    $75.17B
  • Div Yield
    0.48%
  • Trading Activity
    -
$781.49
52W Low: $555.51
25 Sep 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $555.51 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!